In addition to its treatment for a progressive form of blindness, the company has also been testing a way to combat hemophilia B, a blood clotting disorder, by intravenous treatment with viruses ...
Spark Therapeutics The company’s focus is on developing one-time, life-altering treatments for debilitating genetic diseases, a whole new model of personalized, precise treatment.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Spark says it is focussed on expanding its SPK-26 cost cutting program to improve its financial performance, and is on track to deliver its net labour cost reduction target of NZ$50 million a year.
Spark New Zealand lowered earnings guidance and said it plans to sell assets as a weak economy curbs demand for mobile and information technology services. Operating earnings could be as much as ...
AVL, a leading development, simulation, and testing automotive company has partnered with Spark EV Technology, a zero-emission energy and range management specialist to accelerate the development ...